Lucira Health, Inc. (LHDX): Price and Financial Metrics


Lucira Health, Inc. (LHDX): $7.88

-0.02 (-0.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LHDX Stock Price Chart Interactive Chart >

Price chart for LHDX

LHDX Price/Volume Stats

Current price $7.88 52-week high $37.99
Prev. close $7.90 52-week low $4.23
Day low $7.81 Volume 286,900
Day high $8.19 Avg. volume 1,327,841
50-day MA $8.78 Dividend yield N/A
200-day MA $0.00 Market Cap 304.95M

Lucira Health, Inc. (LHDX) Company Bio


Lucira Health, Inc. produces and distributes medical equipment. The Company offers disposable test kits to detect DNA and RNA of infectious diseases. Lucira Health markets its products in the United States.


LHDX Latest News Stream


Event/Time News Detail
Loading, please wait...

LHDX Latest Social Stream


Loading social stream, please wait...

View Full LHDX Social Stream

Latest LHDX News From Around the Web

Below are the latest news stories about Lucira Health Inc that investors may wish to consider to help them evaluate LHDX as an investment opportunity.

LUCIRA™ HEALTH Hires Ghazi Kashmolah as Chief Quality Officer and EVP Regulatory Affairs

EMERYVILLE, Calif., August 23, 2021--Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced life science professional Ghazi Kashmolah has joined the company as Chief Quality Officer and Executive Vice President Regulatory Affairs.

Yahoo | August 23, 2021

3 Beaten-Down Biotech Stocks to Buy Right Now

Volatility comes with the territory when you invest in biotech stocks. Here's why they chose Bluebird Bio (NASDAQ: BLUE), Lucira Health (NASDAQ: LHDX), and Vertex Pharmaceuticals (NASDAQ: VRTX). Prosper Junior Bakiny (Bluebird Bio): Shares of Bluebird Bio have been hammered in recent years.

Yahoo | August 18, 2021

Lucira Health, Inc. (LHDX) Q2 2021 Earnings Call Transcript

After the speakers' presentation, there will be a question-and-answer session [Operator instructions] I would now like to hand the conference over to your first speaker today, Hannah Jeffrey from Gilmartin Group. Earlier today, Lucira Health released financial results for the second quarter ended June 30, 2021. Joining me today on today's call are Erik Engelson, president and chief executive officer; and Dan George, chief financial officer.

Yahoo | August 13, 2021

Lucira Health Announces Second Quarter 2021 Financial Results

EMERYVILLE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported financial results for the second quarter ended June 30, 2021. Recent Highlights Recorded record-high revenue of $12.4 million for the second quarter of 2021, representing 175% sequential growth from the previo

Yahoo | August 12, 2021

Will Lucira Health (NASDAQ:LHDX) Spend Its Cash Wisely?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Yahoo | August 3, 2021

Read More 'LHDX' Stories Here

LHDX Price Returns

1-mo -19.59%
3-mo 56.66%
6-mo -44.82%
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7092 seconds.